569
Participants
Start Date
November 29, 2001
Primary Completion Date
January 15, 2004
Study Completion Date
January 15, 2004
Tarceva (erlotinib HCl, OSI-774)
Prince of Wales Hospital, Randwick
Concord Hospital, Concord
Newcastle Mater Hospital, HRMC Waratah
Clinical County Hospital Sibiu, Sibiu
Austin & Repatriation Medical Centre, Heidelberg
Frankston Hospital, Frankston
Oncology Institute Ion Chiricuta, Cluj-Napoca
Royal Adelaide Hospital, Adelaide
The Queen Elizabeth Hospital, Woodville South
Ashford Cancer Centre, Ashford
St. Spiridon University Hospital, Iași
New York University School of Medicine, New York
St Luke's-Roosevelt Hospital, New York
Arena Oncology Associates, Great Neck
Charite Campus Virchow Klinikum, Berlin
Instituto Nacional De Cancerologia, Mexico City
Interlakes Oncology & Hematology, P.C., Rochester
Hematology & Oncolgy Assoc of NE PA, Dunmore
University of Pennsylvania Cancer Center, Philadelphia
Pennsylvania Oncology Hematology Associates, Philadelphia
Fox Chase Cancer Center, Philadelphia
Sinai Hospital, Baltimore
The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore
Annapolis Medical Specialists, Annapolis
Hematology & Oncology Associates of Virginia, Ltd., Richmond
Presbyterian Hospital, Charlotte
Charleston Hematology/Oncology, Charleston
Atlanta Cancer Center, Atlanta
Rambam Medical Center, Haifa
Oncology Hematology Group of South Florida, Miami
Tampa General Hospital, Tampa
Ocala Oncology, Ocala
Sarah Cannon Cancer Center, Nashville
Norton Healthcare, Inc., Louisville
Universitatsklinikum Essen, Essen
Rabin Medical Center (Belinson Campus), Petach Tiqva
University of Iowa Hospital & Clinics, Iowa City
Chaim Sheba Medical Center, Tel Litwinsky
Oncology of Wisconsin, Milwaukee
University of Minnesota, Minneapolis
Odyssey Research Services, Bismarck
Hematology Oncology Associates of Illinois, Skokie
Onc/Hem Associates of Central Illinois, Peoria
Carle Cancer Center, Urbana
Kansas City Oncology and Hematology Group, Kansas City
Sourasky Medical Center (Ichikov), Tel Aviv
University of Kansas Medical Center, Kansas City
Universitatskliniken des Saarlands Innere Medizin II, Hamburg
Universitatskliniken des Saarlands, Homburg
J Gurtler, Hematology and Oncology, Metairie
Mary Bird Perkins Cancer Center, Baton Rouge
Highlands Oncology Group, Springdale
Tyler Hematology Oncology PA, Tyler
Arlington Cancer Centre, Arlington
MD Anderson Cancer Center, Houston
Southwest Regional Cancer Center, Austin
Arizona Clinical Research Center, Tucson
Metropolitan Hematology/Oncology Medical Group, Inc., Los Angeles
UCLA Medical Center, Los Angeles
Azienda Ospedaliera Universitaria Policlinico A.O.V.P. Oncologia Medica, Palermo
Auckland Hospital, Auckland
Kaiser Permanente, San Diego
Loma Linda University Cancer Institute, Loma Linda
Alta Bates Comprehensive Cancer Center, Berkeley
Medizinische Poliklinik der Universitaet Wurzburg, Würzburg
Western Washington Oncology Inc., Olympia
Southwest Washington Medical Center, Vancouver
National University Hospital, Singapore
Singapore General Hospital, Singapore
National Cancer Centre, Singapore
DeQuattro Community Cancer Center, Manchester
New Britain General Hospital, New Britain
Eastern Connecticut Oncology, Norwich
Carl and Dorothy Bennett Cancer Center, Stamford
Florida Cancer Specialists, Fort Myers
University of Kentucky, Lexington
St Elizabeth Medical Center, Boston
New England Medical Center, Boston
Berkshire Hematology & Oncology, PC, Pittsfield
Baystate Medical Center, Springfield
New Hampshire Oncology-Hematology PA, Hooksett
St Barnabas Medical Center, Livingston
Stony Brook University Hospital, Stony Brook
University Hospitals of Cleveland, Cleveland
Chiles Research Cancer Center, Portland
Green Mountain Oncology Group, Bennington
Hospital Italiano de Buenos Aires, Buenos Aires
Hospital Britanico, Buenos Aires
Instituto Oncologico Angel Roffo, Buenos Aires
Instituto Alexander Fleming, Buenos Aires
Hospital Churruca Visca, Buenos Aires
Centro Medico Confidence, Buenos Aires
Institute Jules Bordet, Brussels
Clinica Las Condes, Las Condes
Innere MedizinUniversitatsklinikum Heidelberg, Heidelberg
Kaplan Medical Center, Rehovot
Christchurch HospitalClinical Oncology Hospital, Christchurch
Nucleo de Oncolgia da Bahia, Salvador
Hospital Vera Cruz S/A, Barro Prêto
Irmandade Santa Casa de Misericordia de Porto Alegre, Porto Alegre
Hospital Israelita Albert Einstein, São Paulo
Cross Cancer Institute, Edmonton
BC Cancer Centre for the Southern Interior, Kelowna
Pentincton Regional Hospital, Pentincton
Fraser Valley Cancer Centre, Surrey
BCCA VAncouver Centre, Vancouver
BCCA- Vancouver Island Centre, Victoria
CancerCare Manitoba (CCMB), Winnipeg
Saint John Regional Hospital, Saint John
Dr. H. Bliss Murphy Cancer Centre, St. John's
QEII Health Sciences Centre, Halifax
Hamilton Regional Cancer Centre, Hamilton
Kingston Regional Cancer Centre, Kingston
London Regional Cancer Center, London
Credit Valley Hospital, Mississauga
Ottawa Regional Cancer Centre, Ottawa
Group Health Centre, Saulte Ste. Marie
Hotel Dieu Health Sciences HospitalNiagra, St. Catharines
Toronto East General Hospital, Toronto
Toronto-Sunnybrook Regional Cancer Center, Toronto
Princess Margaret Hospital, Toronto
St Joseph's Health Centre, Toronto
Hopital Maisonneuve-Rosemont, Montreal
Hopital Du Sacre-Coeur, Montreal
Hopital Laval, Ste-Foy
Allan Blair Cancer Centre, Regina
Tumor Biology Center, Freiburg im Breisgau
"Anticancer Hospital of Thessaloniki THEAGENIO", Thessaloniki
"District General Hospital of Thessaloniki HIPPOKRATION", Thessaloniki
Great Poland Cancer Centre, Poznan
Dolnoslaskie Centrum Onkologii, Wroclaw
ICRF Medical Oncology Unit, Oxford
Velindre Hospital, Cardiff
Russell's Hall HospitalDepartment of OncologyGeorgina Unit, Dudley
Deanesly Centre, Wolverhampton
The Princess Royal Hospital, Hull
St. Bartholomews Hospital, London
North Middlesex Hospital, London
Department of Medical Oncology, Manchester
Newcastle General Hospital, Newcastle upon Tyne
Lead Sponsor
Canadian Cancer Trials Group
NETWORK
OSI Pharmaceuticals
INDUSTRY